Overall, all current studies highlight that YAP/TAZ represent a hub for the aggressiveness and recurrence of TNBC, and combinational inhibition of YAP/TAZ activity in TNBC treatment may serve as an effective strategy for avoiding tumour metastasis and overcoming drug resistance. This evidence concerns the gene YAP1 and neoplasm.